Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum paraoxonase activity changes in uremic and kidney-transplanted patients.

Nephron - 1 Jan 1999

Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G

Abstract excerpt

Serum paraoxonase (PON) is a high-density lipoprotein (HDL)-associated hydrolase, which inhibits low-density lipoprotein oxidation. Uremic and kidney-transplanted patients have an increased risk of atherosclerosis, to which an increased lipoprotein oxidation may contribute. The aim of our study was to determine whether the PON activity or phenotype is altered in uremic and kidney-transplanted patients, and to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryldialkylphosphatase
Share to Carboxylic Ester Hydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol

Share to Esterases

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Triglycerides

Share to Uremia

Source

Identifiers

PMID: 10516491
DOI: 10.1159/000045489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum paraoxonase activity changes in uremic and kidney-transplanted patients.PMID 10516491Read ↗

Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.Semantic proximity Read ↗

HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.Semantic proximity Read ↗

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.Semantic proximity Read ↗

Paraoxonase activity in healthy, diabetic, and hemodialysis patients.Semantic proximity Read ↗

Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.Semantic proximity Read ↗

Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.Semantic proximity Read ↗

Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.Semantic proximity Read ↗

Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women.Semantic proximity Read ↗

Associations between Apolipoprotein E Gene Polymorphisms and Cardiovascular Complications of Uremic Patients on Maintenance Hemodialysis.Semantic proximity Read ↗

Paraoxonase 1 gene polymorphisms concerning non-insulin-dependent diabetes mellitus nephropathy in hemodialysis patients.Semantic proximity Read ↗

Oxidative stress and hemoglobin-cholesterol adduct in renal patients with different LDL phenotypes.Semantic proximity Read ↗

Paraoxonase phenotype distribution in a healthy Iranian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.